SITC Publishes Third Manuscript in JITC Special Series on the Current Challenges and Opportunities in Cancer Immunotherapy

By SITC Scientific Publications News posted 22 hours ago
SITC is pleased to announce the publication of a new manuscript titled “A SITC Strategic Vision: Prevention, Premalignant Immunity, Host and Environmental Factors,” available now in the Journal for ImmunoTherapy of Cancer ( JITC ). This manuscript is the third in a JITC Special Series — The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer, which outlines the current state of the field, elevates the ...
0 comments

Call for Comment: SITC Renal Cell Carcinoma CPG v3.0 Until May 8

By SITC Scientific Publications News posted 22 days ago
Manuscript Title: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma v3.0 Draft Manuscript Summary The Society for Immunotherapy of Cancer (SITC) Renal Cell Carcinoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical practice ...
0 comments

JITC Digest April 2025

By JITC Publications posted 28 days ago
INSIDE THIS ISSUE: Letter from the Editor | JITC Editor Picks | JITC at AACR 2025 40 th Anniversary Series | Popular Archive Articles Letter from the Editor Hello JITC Readers, I just returned from London with other Editors-in-Chief for the 76 journals (like ours) published by the BMJ Group. We focused on many issues that confront our knowledge workers in ...
0 comments

SITC Publishes Manuscript on Essential Biomarkers for Immunotherapy Clinical Protocols

By SITC Scientific Publications News posted 04-01-2025
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive manuscript, “Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols” in the Journal for ImmunoTherapy of Cancer (JITC) . This work provides an in-depth examination of evidence-based biomarkers that measure the potential for therapeutic response and/or toxicity that are critical ...
0 comments

Lymphoma CPG Update V1.4 Now Available

By SITC Scientific Publications News posted 03-24-2025
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma ” is now available. In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline content. This is done ...
0 comments

SITC Publishes Second Manuscript in JITC Special Series on the Current Challenges and Opportunities in Cancer Immunotherapy

By SITC Scientific Publications News posted 03-24-2025
On behalf of SITC, we are pleased to announce the publication of a new manuscript titled, “ A SITC Vision: Adapting Clinical Trials to Accelerate Drug Development in Cancer Immunotherapy ” available now in the Journal for ImmunoTherapy of Cancer ( JITC ). This manuscript is the second in a JITC Special Series — The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer, which outlines the current state of the field, ...
0 comments

JITC Digest March 2025

By JITC Publications posted 03-19-2025
INSIDE THIS ISSUE: Letter from the Editor | JITC Editor Picks | Popular Archive Articles Letter from the Editor Dear Readers, We find ourselves amid a rather unsettling period for scientists and cancer clinicians in the nation, and by reflection, around the world. We join our deeply concerned colleagues at both the US National Institutes of Health (NIH) and the National ...
0 comments

Melanoma CPG Addendum v3.2 Now Available

By SITC Scientific Publications News posted 03-18-2025
An addendum to the " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma " is now available. In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline content. This is ...
0 comments

SITC Invites Public Comment on ICI Long-Term Toxicities and Survivorship Manuscript

By SITC Scientific Publications News posted 03-07-2025
Manuscript Title: Where's the data? Delayed and chronic irAE management and surveillance after cessation of immune checkpoint inhibitors: Expert insights from SITC on survivorship care and the need for long-term data Draft Manuscript Summary Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering durable responses and prolonged survival. However, these therapies also present unique challenges, particularly ...
0 comments

Apply to Join the Cancer Immunotherapy Guidelines Oversight Committee

By SITC Scientific Publications News posted 02-26-2025
The Society for Immunotherapy of Cancer (SITC) is seeking volunteers to join the Cancer Immunotherapy Guidelines (CIG) Oversight Committee, which plays a key role in guiding the society’s clinical practice guideline development and dissemination strategy. The CIG Oversight Committee oversees the development and updating of new and existing cancer immunotherapy clinical practice guidelines (CPGs) by setting the policies and protocols for SITC guidelines ...
0 comments

Head and Neck Squamous Cell Carcinoma CPG Update v1.1 Now Available

By SITC Scientific Publications News posted 11-18-2024
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of head and neck squamous cell carcinoma ” is now available. In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline ...
0 comments

Public Comment on USCDI Cancer Immune-related Adverse Events Draft Dataset

By SITC Scientific Publications News posted 11-05-2024
The Society for Immunotherapy of Cancer is pleased to share a collaborative effort between the HHS Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP), the National Cancer Institute (NCI), and Food and Drug Administration (FDA) focused on the release of the USCDI+ Cancer Immune-related Adverse Events (irAE) draft dataset. The goal of this data set is to enhance the accuracy and reliability ...
0 comments

Urothelial Cancer CPG Update v2.4 Now Available

By SITC Scientific Publications News posted 11-01-2024
An update to " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer " is now available. In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline content. ...
0 comments

SITC Biomarker Committee Publishes Manuscript on Biomarker Development for PD-(L)1 Axis Inhibition

By SITC Scientific Publications News posted 08-19-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a review manuscript titled " Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee ." Understanding the mechanisms that drive PD-L(1) inhibitor resistance and the development of predictive biomarkers is key in advancing the field of immunotherapy. To address this significant hurdle in the field, SITC convened ...
0 comments

SITC CPG Mobile App Receives 2024 President's Award from the American Association of Medical Society Executives

By SITC Scientific Publications News posted 08-06-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce that the SITC Clinical Practice Guidelines (CPG) Mobile App has been selected by the American Association of Medical Society Executives (AAMSE) to receive the President’s Award as part of their Profiles of Excellence (PoE) Award Program. The PoE Awards are issued in five different categories to recognize organizations for their efforts in advancing the field of organized medicine ...
0 comments

SITC Publishes Commentary on a Crisis in Clinical Research

By SITC Scientific Publications News posted 07-22-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary detailing what is being described as a Crisis in Clinical Research . The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical ...
0 comments

ICI-Related Adverse Events CPG Updates v1.1 and v1.2 Now Available

By SITC Scientific Publications News posted 07-18-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline content. This is done through our “ SITC Living Guidelines ” rapid update protocols designed to ensure SITC’s CPGs are up-to-date with cutting-edge thinking and incorporate the leading ...
0 comments

SITC Publishes First Manuscript in JITC Special Series on the Current Challenges and Opportunities in Cancer Immunotherapy

By SITC Scientific Publications News posted 06-20-2024
On behalf of the SITC Board of Directors, we are pleased to announce the publication of a new manuscript titled, “ Challenges and Opportunities in Cancer Immunotherapy: A Society for Immunotherapy of Cancer (SITC) Strategic Vision ” available now in the Journal for ImmunoTherapy of Cancer (JITC) . This manuscript is the first in a JITC Special Series — The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer ...
0 comments

Breast Cancer CPG Update v1.2 Now Available

By SITC Scientific Publications News posted 06-11-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, treatment algorithms, or other guideline content. This is done through our “ SITC Living Guidelines ” rapid update protocols designed to ensure SITC’s CPGs are up-to-date with cutting-edge thinking and incorporate the ...
0 comments

SITC Publishes Collaborative Manuscript on Recommendations for Tumor Mutational Burden Assay Validation and Reporting

By SITC Scientific Publications News posted 06-05-2024
On behalf of the Society for Immunotherapy of Cancer (SITC) and in collaboration with the Association for Molecular Pathology (AMP) and the College of American Pathologists (CAP), we are pleased to announce the publication of a new manuscript titled " Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society ...
0 comments